You are here
Thomas E. Stinchcombe, MD, is Medical Oncologist in Chapel Hill, North Carolina. He is currently a full professor in Department of Medicine, Division of Medical Oncology of the Duke University Medical Center, Durham, North Carolina. Dr. Stinchcombe is a member for the Thoracic Oncology Program within the Duke Cancer Institute. For 2016‒2017 65% of his professional effort will be devoted to clinical activities.
Dr. Stinchcombe received his medical degree from the University of Virginia, School of Medicine in 1995 and completed his internal medicine residency at the University of Michigan in 1998. This was followed by a Hemotology and Oncology fellowship at the University of North Carolina from 1998‒2001.
Research activities and publications
His clinical interest is in thoracic malignancies, and his research focus is clinical trials for non-small-cell and small-cell lung cancer.
Dr. Stinchcombe acts as Associate Editor of the Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer (IASLC). He is Editorial Board Member of Clinical Lung Cancer and Lung Cancer and formerly of the Journal of Clinical Oncology and Lancet Respiratory Medicine. Dr. Stinchcombe is reviewer of various oncology journals and funding societies. Her published around hundred articles in peer-reviewed journals and authored different specialized book chapters.
Committees and Advisory Boards
Dr. Stinchcombe is Co-Chair of the Hoosier Oncology Network (HCRN) Thoracic Oncology. He is assigned to the united Board of Directors of the Academic and Community Cancer Research and Co-Chair in its thoracic disease group. He is Committee Cadre Member of the Cancer and Leukemia Group B. He is member of the International Association for the Study of Lung Cancer Communications Committee and the American Lung Association Lung Force Research Project, Lung Cancer in Woman Peer Review Committee. Additionally, Dr. Stinchcombe is on the Hoosier Cancer Research Network Data Safety Monitoring Board. He was in the Academic Thoracic Oncology Medical Investigator’s Consortium (ATOMIC) from 2014‒2016, and is Co-Principal Investigator for the Alliance the Duke Network and in the National Investigator Steering Committee.